Cargando…
Biological targets for therapeutic interventions in COPD: clinical potential
COPD is a widespread inflammatory respiratory disorder characterized by a progressive, poorly reversible airflow limitation. Currently available therapies are mostly based on those used to treat asthma. However, such compounds are not able to effectively reduce the gradual functional deterioration,...
Autores principales: | Pelaia, Girolamo, Vatrella, Alessandro, Gallelli, Luca, Renda, Teresa, Caputi, Mario, Maselli, Rosario, Marsico, Serafino A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707155/ https://www.ncbi.nlm.nih.gov/pubmed/18046869 |
Ejemplares similares
-
Respiratory infections and asthma
por: Pelaia, Girolamo, et al.
Publicado: (2006) -
Update on optimal use of omalizumab in management of asthma
por: Pelaia, Girolamo, et al.
Publicado: (2011) -
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD
por: Pelaia, Girolamo, et al.
Publicado: (2015) -
Application of Proteomics and Peptidomics to COPD
por: Pelaia, Girolamo, et al.
Publicado: (2014) -
Update on Anticytokine Treatment for Asthma
por: Gallelli, Luca, et al.
Publicado: (2013)